Redhill Biopharma
RDHL
55 hedge funds and large institutions have $77.4M invested in Redhill Biopharma in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 14 reducing their positions, and 8 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
29% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 14
21% more call options, than puts
Call options by funds: $3.9M | Put options by funds: $3.22M
19% more capital invested
Capital invested by funds: $65M → $77.4M (+$12.4M)
6% more funds holding
Funds holding: 52 → 55 (+3)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$5.91M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$5.29M |
| 3 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$5.11M |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$3.83M |
| 5 |
II
Ibex Investors
Denver,
Colorado
|
+$2.72M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIFH
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
|
-$2.7M |
| 2 |
DGI
Disciplined Growth Investors
Minneapolis,
Minnesota
|
-$1.68M |
| 3 |
SC
Sculptor Capital
New York
|
-$1.09M |
| 4 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$671K |
| 5 |
Goldman Sachs
New York
|
-$495K |
RDHL Hedge Fund Activity: Q1 2021 in Review
55 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q1 2021, worth a combined $77.4M — up 19% from $65M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new RDHL positions and 8 closed out — a net gain of 4 holders — while 18 added to existing stakes and 14 trimmed.
The largest buyer was Great Point Partners, opening a new position worth an estimated $5.91M. The largest seller was Migdal Insurance & Financial Holdings, cutting an estimated $2.7M.
- 55 institutional investors held Redhill Biopharma (RDHL) as of Q1 2021, up from 52 in Q4 2020.
- Funds reported $77.4M of Redhill Biopharma stock for Q1 2021, up 19% quarter-over-quarter.
- 12 funds opened new Redhill Biopharma positions in Q1 2021 and 8 closed out, a net change of +4 holders.
- The largest Redhill Biopharma buyer in Q1 2021 was Great Point Partners, an estimated $5.91M added.
- The largest Redhill Biopharma seller in Q1 2021 was Migdal Insurance & Financial Holdings, an estimated $2.7M sold.
Based on aggregated 13F filings for Q1 2021.